Kala Pharmaceuticals (KALA) Reports Q2 Loss of $4.36

Kala Pharmaceuticals (NASDAQ: KALA) reported Q2 EPS of ($4.36).

For earnings history and earnings-related data on Kala Pharmaceuticals (KALA) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Morgan Stanley course-corrects their semiconductor equipment outlook on demand
• S&P 500 may pull back before midterms, but Citi says buy the dip